This retrospective observational study aims to determine the incidence of acute kidneyinjury (AKI) associated with COVID-19, risk factors, and effects on mortality forintensive care unit patients. Data from 238 COVID-19 patients monitored in theAnesthesiology and Reanimation Intensive Care Unit of Ankara University Ibni SinaHospital between January 1, 2021 and January 1, 2022 were retrospectively reviewed.Patients were divided into two groups according to the level of renal damage (with andwithout AKI). Those with AKI were staged per the KDIGO criteria (Stage 1-2-3).Demographic data, comorbidities, Charlson comorbidity indexes, Acute Physiology andChronic Health Evaluation scores, laboratory results, and mortality data were examined.The data obtained were compared between the groups.The findings may help improve clinical awareness and guide management strategies inintensive care unit patients with COVID-19 at risk of AKI
This retrospective, single-center observational study was conducted at Ankara University
Hospital. Data from 238 COVID-19 patients monitored in the Anesthesiology and Reanimation
Intensive Care Unit of Ankara University Ibni Sina Hospital between January 1, 2021 and
January 1, 2022 were retrospectively reviewed. The objective of the study was to
investigate the frequency, risk factors, and impact on mortality of acute kidney injury
(AKI) in adult patients hospitalized with confirmed COVID-19 infection.
Patients with a confirmed diagnosis of COVID-19 and available renal function data were
included in the analysis. AKI was defined and staged according to the Kidney Disease:
Improving Global Outcomes (KDIGO) criteria. Demographic characteristics, comorbidities,
laboratory values, and clinical parameters were evaluated to identify potential risk
factors for AKI development. The relationship between the presence and severity of AKI
and in-hospital mortality was assessed.
The study aims to provide insight into the burden of COVID-19-associated AKI and to
support improved clinical decision-making for identifying and managing high-risk patients
in hospital settings.
Inclusion Criteria:
- Age 18 years or older
- Hospitalized patients with COVID-19 confirmed by PCR test
- Required follow-up in the intensive care unit between January 1, 2021 and January 1,
2022
Exclusion Criteria:
- Patients with end-stage renal disease (ESRD)
- History of renal transplantation
- Intensive care unit stay shorter than 48 hours
Ankara University
Ankara, Turkey